MY146275A - 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives - Google Patents

4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives

Info

Publication number
MY146275A
MY146275A MYPI20083110A MYPI20083110A MY146275A MY 146275 A MY146275 A MY 146275A MY PI20083110 A MYPI20083110 A MY PI20083110A MY PI20083110 A MYPI20083110 A MY PI20083110A MY 146275 A MY146275 A MY 146275A
Authority
MY
Malaysia
Prior art keywords
methylaminoquinazoline
benzoylaminophenyl
dimethoxy
derivatives
optionally substituted
Prior art date
Application number
MYPI20083110A
Other languages
English (en)
Inventor
Miyazaki Kazuki
Kusano Kazutomi
Takase Yasutaka
Asano Osamu
Shirato Manabu
Wakita Hisashi
Ishii Naoto
Saeki Takao
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MY146275A publication Critical patent/MY146275A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI20083110A 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives MY146275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
MY146275A true MY146275A (en) 2012-07-31

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20083110A MY146275A (en) 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives

Country Status (17)

Country Link
JP (1) JP4778550B2 (sr)
KR (1) KR101278852B1 (sr)
AT (1) ATE517875T1 (sr)
BR (1) BRPI0708098B8 (sr)
CY (1) CY1112554T1 (sr)
DK (1) DK1992622T3 (sr)
ES (1) ES2368089T3 (sr)
HR (1) HRP20110604T1 (sr)
IL (1) IL193322A (sr)
JO (1) JO2726B1 (sr)
MY (1) MY146275A (sr)
NZ (1) NZ569936A (sr)
PT (1) PT1992622E (sr)
RS (1) RS51969B (sr)
RU (1) RU2431632C2 (sr)
SI (1) SI1992622T1 (sr)
TW (1) TWI404709B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
CA2696793A1 (en) 2007-08-17 2009-02-26 Eisai R&D Management Co., Ltd. Novel preparation for external use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
US6262069B1 (en) * 1997-08-29 2001-07-17 Protherics Molecular Design Limited 1-amino-7-isoquinoline derivatives as serine protease inhibitors
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
US7687502B2 (en) * 2004-03-23 2010-03-30 Banyu Pharmaceutical Co., Ltd. Substituted quinazoline or pyridopyrimidine derivative

Also Published As

Publication number Publication date
SI1992622T1 (sl) 2011-11-30
DK1992622T3 (da) 2011-09-05
JPWO2007097317A1 (ja) 2009-07-16
TWI404709B (zh) 2013-08-11
JO2726B1 (en) 2013-09-15
RS51969B (sr) 2012-02-29
KR20080094811A (ko) 2008-10-24
BRPI0708098A2 (pt) 2011-05-17
TW200812980A (en) 2008-03-16
PT1992622E (pt) 2011-09-19
KR101278852B1 (ko) 2013-07-01
ES2368089T3 (es) 2011-11-14
ATE517875T1 (de) 2011-08-15
CY1112554T1 (el) 2016-02-10
IL193322A0 (en) 2009-05-04
JP4778550B2 (ja) 2011-09-21
RU2008137654A (ru) 2010-03-27
HRP20110604T1 (hr) 2011-09-30
IL193322A (en) 2014-04-30
HK1122025A1 (en) 2009-05-08
NZ569936A (en) 2010-07-30
BRPI0708098B1 (pt) 2019-08-06
RU2431632C2 (ru) 2011-10-20
BRPI0708098B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
MY158982A (en) Heterocyclic compound
HRP20120323T1 (en) Diarylhydantoin compounds
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
WO2009028629A1 (ja) 複素環化合物およびその用途
AU2006304874A8 (en) Pyrimidinones as casein kinase II (CK2) modulators
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
WO2008083248A3 (en) Cyclopamine analogs
TNSN08191A1 (en) Kinase inhibitors
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
WO2009041705A3 (en) 5-membered heterocyclic compounds as proton pump inhibitors
WO2008019395A3 (en) Compounds for improving learning and memory
WO2009068463A3 (en) Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
WO2008155666A3 (en) Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
WO2008153129A1 (ja) 尿酸値低下剤
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2009028387A1 (ja) プロテアーゼ阻害剤耐性を有する癌の治療薬